Jie Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jie Xu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Baixin Shen
The Second Affiliated Hospital of Nanjing Medical University
1 shared publication- Chengcheng Yang
Department of Urology, Jiangsu Key Laboratory of Urological Disease Prevention and Treatment, The Second Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, 210008 Nanjing, Jiangsu, China
1 shared publication Jun Xue
The Second Affiliated Hospital of Nanjing Medical University
1 shared publicationJunqi Zhang
Department of Urology, Jiangsu Key Laboratory of Urological Disease Prevention and Treatment, The Second Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, 210008 Nanjing, Jiangsu, China
1 shared publication- Min Gu
Department of Urology, Jiangsu Key Laboratory of Urological Disease Prevention and Treatment, The Second Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, 210008 Nanjing, Jiangsu, China
1 shared publication Ming Zheng
Department of Urology, Jiangsu Key Laboratory of Urological Disease Prevention and Treatment, The Second Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, 210008 Nanjing, Jiangsu, China
1 shared publication
Latest Publications
- Open Access
- 30 September 2026
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 31 (10)
Iguratimod Modulates M1 Macrophage Polarization Via the NOTCH4–KLF4 Axis to Alleviate Antibody-Mediated Rejection
Background: Iguratimod (IGT) is a small-molecule anti-inflammatory agent that effectively attenuates the progression of antibody-mediated rejection (ABMR). However, the underlying mechanism of action of IGT remains poorly understood. Thus, this study aimed to investigate the mechanism through which IGT regulates macrophage polarization and ABMR. Methods: A mouse model of ABMR was established by performing kidney transplantation after skin graft-induced sensitization. Experimental interventions included neurogenic locus notch homolog protein 4 (NOTCH4) knockout mice and oral administration of IGT. RNA sequencing, quantitative polymerase chain reaction, Western blotting (WB), flow cytometry, and immunofluorescence (IF) staining were performed to investigate M1 macrophage polarization and the Jagged1–NOTCH4 signaling pathway. Results: This study found that IGT significantly reduced M1 macrophage infiltration into renal allografts in a mouse model of ABMR. Transcriptomic sequencing and subsequent biological experiments indicated that IGT may regulate macrophage polarization through the Jagged1–NOTCH4 pathway. Conclusion: M1 macrophage polarization may contribute to the initiation and progression of ABMR following kidney transplantation. IGT attenuates M1 macrophage polarization by inhibiting Jagged1–NOTCH4–Krüppel-like Factor 4 (KLF4) signaling.
- 30 September 2026
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 31 (10)
Open AccessIguratimod Modulates M1 Macrophage Polarization Via the NOTCH4–KLF4 Axis to Alleviate Antibody-Mediated Rejection
Background: Iguratimod (IGT) is a small-molecule anti-inflammatory agent that effectively attenuates the progression of antibody-mediated rejection (ABMR). However, the underlying mechanism of action of IGT remains poorly understood. Thus, this study aimed to investigate the mechanism through which IGT regulates macrophage polarization and ABMR. Methods: A mouse model of ABMR was established by performing kidney transplantation after skin graft-induced sensitization. Experimental interventions included neurogenic locus notch homolog protein 4 (NOTCH4) knockout mice and oral administration of IGT. RNA sequencing, quantitative polymerase chain reaction, Western blotting (WB), flow cytometry, and immunofluorescence (IF) staining were performed to investigate M1 macrophage polarization and the Jagged1–NOTCH4 signaling pathway. Results: This study found that IGT significantly reduced M1 macrophage infiltration into renal allografts in a mouse model of ABMR. Transcriptomic sequencing and subsequent biological experiments indicated that IGT may regulate macrophage polarization through the Jagged1–NOTCH4 pathway. Conclusion: M1 macrophage polarization may contribute to the initiation and progression of ABMR following kidney transplantation. IGT attenuates M1 macrophage polarization by inhibiting Jagged1–NOTCH4–Krüppel-like Factor 4 (KLF4) signaling.
- Open Access
- 13 September 2024
- Published by Wiley
Proteomic Insights into Diabetic Cystopathy: Identifying Key Protein Expression Changes in Bladder Tissue
Diabetic cystopathy (DCP) is a prevalent urinary complication in diabetes. Late-stage DCP can cause chronic urinary retention, significantly impacting the patient’s quality of life and even posing a risk to their lives. Therefore, it is crucial to investigate the pathogenesis and pathological characteristics of DCP. This study aims to utilize proteomics-related methods to uncover the pathogenesis of DCP by analyzing the differential protein expression profiles in the bladder tissue of diabetic rats and normal rats. Morphological analysis revealed notable changes in the bladder tissue of diabetic rats, including significant inflammatory cell infiltration and collagen fiber deposition. Immunohistological examination demonstrated increased apoptosis and decreased proliferation in the bladder tissue of diabetic rats. Quantitative proteomic analysis identified a total of 280 differentially expressed proteins between the two groups, with 193 proteins being down-regulated and 87 proteins being up-regulated. Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways indicated significant changes in protein expression profiles and signaling pathways in the bladder of diabetic rats. Additionally, transcription factor analysis revealed that the insulin-like growth factor-related protein family was the most affected. This study provides valuable evidence for identifying potential genes for the treatment of diabetic bladder.
- 13 September 2024
- Published by Wiley
Open AccessProteomic Insights into Diabetic Cystopathy: Identifying Key Protein Expression Changes in Bladder Tissue
Diabetic cystopathy (DCP) is a prevalent urinary complication in diabetes. Late-stage DCP can cause chronic urinary retention, significantly impacting the patient’s quality of life and even posing a risk to their lives. Therefore, it is crucial to investigate the pathogenesis and pathological characteristics of DCP. This study aims to utilize proteomics-related methods to uncover the pathogenesis of DCP by analyzing the differential protein expression profiles in the bladder tissue of diabetic rats and normal rats. Morphological analysis revealed notable changes in the bladder tissue of diabetic rats, including significant inflammatory cell infiltration and collagen fiber deposition. Immunohistological examination demonstrated increased apoptosis and decreased proliferation in the bladder tissue of diabetic rats. Quantitative proteomic analysis identified a total of 280 differentially expressed proteins between the two groups, with 193 proteins being down-regulated and 87 proteins being up-regulated. Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways indicated significant changes in protein expression profiles and signaling pathways in the bladder of diabetic rats. Additionally, transcription factor analysis revealed that the insulin-like growth factor-related protein family was the most affected. This study provides valuable evidence for identifying potential genes for the treatment of diabetic bladder.